TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07824583: A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Sponsor: Varian, a Siemens Healthineers Company · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$739,200

Rescue Site Savings

+$508,200

Unlock Full NCT07824583 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07824583 Rescue Dossier →